<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08-PONE-RA-06040R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0004228</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Immunology/Cellular Microbiology and Pathogenesis</subject><subject>Immunology/Immune Response</subject><subject>Immunology/Immunity to Infections</subject><subject>Infectious Diseases/Bacterial Infections</subject><subject>Infectious Diseases/HIV Infection and AIDS</subject><subject>Infectious Diseases/Respiratory Infections</subject></subj-group></article-categories><title-group><article-title>Pleural Tuberculosis in Patients with Early HIV Infection Is Associated with Increased TNF-Alpha Expression and Necrosis in Granulomas</article-title><alt-title alt-title-type="running-head">Increased Necrosis in TB/HIV</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bezuidenhout</surname><given-names>Juanita</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Roberts</surname><given-names>Teri</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Muller</surname><given-names>Liesel</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>van Helden</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Walzl</surname><given-names>Gerhard</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Histopathology, Tygerberg Hospital, Cape Town, Western Cape, South Africa</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Molecular Biology and Human Genetics, MRC Centre for Molecular and Cellular Biology, DST/NRF Centre of Excellence for Biomedical TB Research, Department of Biomedical Sciences, Faculty of Health Sciences, University of Stellenbosch, Cape Town, Western Cape, South Africa</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Marais</surname><given-names>Ben</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">University of Stellenbosch, South Africa</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>teri.roberts@uct.ac.za</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: JB. Performed the experiments: LM. Analyzed the data: JB. Contributed reagents/materials/analysis tools: PDvH GW. Wrote the paper: JB TR GW.</p></fn></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>19</day><month>1</month><year>2009</year></pub-date><volume>4</volume><issue>1</issue><elocation-id>e4228</elocation-id><history><date date-type="received"><day>20</day><month>8</month><year>2008</year></date><date date-type="accepted"><day>23</day><month>11</month><year>2008</year></date></history><copyright-statement>Bezuidenhout et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2009</copyright-year><abstract><p>Although granulomas may be an essential host response against persistent antigens, they are also associated with immunopathology. We investigated whether HIV co-infection affects histopathological appearance and cytokine profiles of pleural granulomas in patients with active pleural tuberculosis (TB). Granulomas were investigated in pleural biopsies from HIV positive and negative TB pleuritis patients. Granulomas were characterised as necrotic or non-necrotic, graded histologically and investigated for the mRNA expression of IL-12, IFN-&#x003b3;, TNF-&#x003b1; and IL-4 by <italic>in situ</italic> hybridisation. In all TB patients a mixed Th1/Th2 profile was noted. Necrotic granulomas were more evident in HIV positive patients with a clear association between TNF-&#x003b1; and necrosis. This study demonstrates immune dysregulation which may include TNF-&#x003b1;-mediated immunopathology at the site of disease in HIV infected pleural TB patients.</p></abstract><counts><page-count count="8"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Granulomas represent a distinctive pattern of chronic inflammation that involves adaptive immunity, and are the hallmark of many human diseases of significance, such as tuberculosis (TB) <xref ref-type="bibr" rid="pone.0004228-Algood1">&#x0005b;1&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Thurlbeck1">&#x0005b;2&#x0005d;</xref>. An important gap in current knowledge is an understanding of how host resistance to TB disease is mediated. The pleura is often involved in active TB disease and this can take on the form of effusions, tuberculous empyema or obliterative fibrous pleuritis <xref ref-type="bibr" rid="pone.0004228-Hasleton1">&#x0005b;3&#x0005d;</xref>. The release of mycobacterial antigens into the pleural space, eliciting a delayed-type hypersensitivity (DTH) reaction <xref ref-type="bibr" rid="pone.0004228-Ellner1">&#x0005b;4&#x0005d;</xref>, may play an important role in the pathogenesis of tuberculous pleurisy. Pleural TB in human immunodeficiency virus (HIV)-negative subjects has been taken to represent more of a protective immune response to <italic>Mycobacterium tuberculosis</italic> (<italic>Mtb</italic>) than other forms of the disease due to the fact that a high proportion of individuals can recover without antibiotic therapy <xref ref-type="bibr" rid="pone.0004228-Roper1">&#x0005b;5&#x0005d;</xref>.</p><p>Granuloma formation is considered to be an essential component of protective immune responses against <italic>Mtb</italic><xref ref-type="bibr" rid="pone.0004228-Saunders1">&#x0005b;6&#x0005d;</xref>. The formation of the granuloma is firmly linked to the DTH reaction, which is a form of adaptive cell-mediated immunity (CMI) that is mediated by activated T lymphocytes and their cytokines. Epithelioid macrophages are present in the centre of the granuloma with some multi-nucleated giant cells and this central area is surrounded by lymphocytes. Dendritic cells may also be present.</p><p>HIV infected people develop TB at a rate of 10&#x00025; per year, rather than the norm of 10&#x00025; per lifetime <xref ref-type="bibr" rid="pone.0004228-Braun1">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Schluger1">&#x0005b;8&#x0005d;</xref>, suggesting that HIV infection may affect the ability of granulomas to contain <italic>Mtb</italic>. It has been hypothesized that quantitative and qualitative T-helper responses may impact on AIDS pathogenesis. Although the supposed role of modulation of T helper responses in HIV pathogenesis remains controversial, a switch in the predominant response from Th1 to Th2 and the production of associated cytokines may facilitate disease progression <xref ref-type="bibr" rid="pone.0004228-Clerici1">&#x0005b;9&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Maggi1">&#x0005b;10&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Vyakarnam1">&#x0005b;11&#x0005d;</xref>. HIV coinfection weakens the granulomatous host response to <italic>Mtb</italic> due to insufficient macrophage, T cell and cytokine responses <xref ref-type="bibr" rid="pone.0004228-Imperiali1">&#x0005b;12&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Lawn1">&#x0005b;13&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Oyaizu1">&#x0005b;14&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Polyak1">&#x0005b;15&#x0005d;</xref>. TB is often an early occurrence in HIV, even before any reduction in CD4&#x0002b; T cell count <xref ref-type="bibr" rid="pone.0004228-Mukadi1">&#x0005b;16&#x0005d;</xref>, and the trafficking of HIV infected, and therefore dysfunctional, cells into the granuloma may lead to granuloma disruption. <italic>Mtb</italic> can also modulate HIV replication by generating a cytokine microenvironment favouring viral infection and spread in local mononuclear cells <xref ref-type="bibr" rid="pone.0004228-Garrait1">&#x0005b;17&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Goletti1">&#x0005b;18&#x0005d;</xref>.</p><p>There is a delicate and complicated interplay between different cytokines and there are numerous reports of beneficial and detrimental effects of individual cytokines. High levels of pro-inflammatory cytokines, including IFN-&#x003b3; and TNF-&#x003b1; <xref ref-type="bibr" rid="pone.0004228-Barnes1">&#x0005b;19&#x0005d;</xref> are found in TB effusions but, in addition to protective effects <xref ref-type="bibr" rid="pone.0004228-Flynn1">&#x0005b;20&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Flynn2">&#x0005b;21&#x0005d;</xref>, there are also reports of detrimental effects of IFN-&#x003b3; <xref ref-type="bibr" rid="pone.0004228-Rhodes1">&#x0005b;22&#x0005d;</xref>, TNF-&#x003b1; <xref ref-type="bibr" rid="pone.0004228-Bekker1">&#x0005b;23&#x0005d;</xref>, and IL-12 <xref ref-type="bibr" rid="pone.0004228-Ehlers1">&#x0005b;24&#x0005d;</xref>, especially if present at high concentrations. The role of IL-4 in the immunopathology of TB <xref ref-type="bibr" rid="pone.0004228-Seah1">&#x0005b;25&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-vanCrevel1">&#x0005b;26&#x0005d;</xref> has been established and may be due to the suppression of the Th1 cytokines IL-12, IFN-&#x003b3; and TNF-&#x003b1;.</p><p>Understanding the human host response is important, as this would assist in the development of new vaccines and immunomodulatory adjuvants for the prevention or treatment of TB. We chose to investigate the Th1/Th2 profile in pleural TB patients by measuring the mRNA expression levels of the cytokines IL-12, IFN-&#x003b3;, TNF-&#x003b1; and IL-4 <italic>in situ</italic>. In addition we compared the cytokine profiles of necrotic and non-necrotic granulomas from HIV-positive and -negative patients in order to describe the association between cytokine production, necrosis and HIV positivity.</p></sec><sec sec-type="materials|methods" id="s2"><title>Materials and Methods</title><sec id="s2a"><title>Study design, participants and tissue specimens</title><p>A total of 12 patients with pleural TB were recruited from Tygerberg Academic Hospital, including 6 HIV sero-negative (group 1) and 6 HIV sero-positive (group 2) people. HIV serology was done on all patients by ELISA. HIV positive patients were in the early stage of the disease and had no opportunistic infections besides TB. All patients presented with symptoms of pleuritis and had radiological confirmation of the effusion. None of the patients had had TB previously nor were any on treatment at the time of the study. Pleural biopsy tissue was obtained for diagnostic purposes. The diagnosis of TB was confirmed by the presence of granulomatous inflammation and Ziehl-Neelsen (ZN) positive bacilli in biopsy material <xref ref-type="bibr" rid="pone.0004228-Lynch1">&#x0005b;27&#x0005d;</xref>. Standard, fixed-dose anti-TB treatment was administered before the patients were referred to TB clinics. No follow-up data on these patients was available. Approval was granted by the Ethics Committee of the University of Stellenbosch. Written, informed consent was obtained from all the participants.</p></sec><sec id="s2b"><title>Preparation of Riboprobes</title><p>This was performed essentially as described previously <xref ref-type="bibr" rid="pone.0004228-Fenhalls1">&#x0005b;28&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Fenhalls2">&#x0005b;29&#x0005d;</xref> using PCR conditions and primer sequences as published elsewhere <xref ref-type="bibr" rid="pone.0004228-Hoefakker1">&#x0005b;30&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Myatt1">&#x0005b;31&#x0005d;</xref>. Briefly, peripheral blood mononuclear cells (PBMCs) were isolated from a healthy volunteer and stimulated for 18 hours with phytohemagglutinin (PHA). Total RNA was extracted and quantified and shown to be undegraded on a 1&#x00025; agarose gel. cDNA was prepared using the Titan system (Boehringer Mannheim). The PCR products were cloned into the vector pGEM7Zf (Promega) and sequencing of the clones confirmed the DNA sequence (<xref ref-type="table" rid="pone-0004228-t001">Table 1</xref>) and ascertained the orientation of the PCR product in order to synthesize sense and antisense riboprobes. After digestion the fragments were separated by electrophoresis on 1&#x00025; agarose gels and extracted. RNA polymerases were used to transcribe digoxigenin-labelled RNA and labelling of the probes was confirmed by Northern blot analysis.</p><table-wrap id="pone-0004228-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004228.t001</object-id><label>Table 1</label><caption><title>Sequences of cytokine riboprobes used in <italic>in situ</italic> hybridisation.</title></caption><graphic id="pone-0004228-t001-1" xlink:href="pone.0004228.t001"/><table frame="hsides" rules="groups" alternate-form-of="pone-0004228-t001-1"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Riboprobe</td><td align="left" rowspan="1" colspan="1">Length (bp)</td><td align="left" rowspan="1" colspan="1">Sequence (5&#x02032; &#x02013; 3&#x02032;)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">TNF-&#x003b1;</td><td align="left" rowspan="1" colspan="1">124</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">TCTCGAACCCCGAGTGACAAGCCTGTAGCCCATGTTGTAGCAAACCCTCAAGCTGAGGGGCAGCTCCAGTGGCTGAACCGCCGGGCCAATGCCCTCCTGGCCAATGGTGTGGAGCTGAGAGATA</named-content></td></tr><tr><td align="left" rowspan="1" colspan="1">IFN-&#x003b3;</td><td align="left" rowspan="1" colspan="1">356</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">AGTTATATCTTGGCTTTTGAGCTCTGCATCGTTTTGGGTTCTCTTGGCTGTTACTGCCAGGACCCATATGTACAAGAAGCAGAAAACCTTAAGAAATATTTTAATGCAGGTCATTCAGATGTAGCGGATAATGGAACTCTTTTCTTAGGCATTTTGAAGAATTGGAAAGAGGAGAGTGACAGAAAAATAATGCAGAGCCAAATTGTCTCCTTTTACTTCAAACTTTTTAAAAACTTTAAAGATGACCAGAGCATCCAAAAGAGTGTGGAGACCATCAAGGAAGACATGAATGTCAAGTTTTTCAATAGCAACAAAAAGAAACGAGATGACTTCGAAAAGCTGACTAATTATTCGGT</named-content></td></tr><tr><td align="left" rowspan="1" colspan="1">IL-4</td><td align="left" rowspan="1" colspan="1">317</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">CTTCCCCCTCTGTTCTTCCTGCTAGCATGTGCCGGCAACTTTGTCCACGGACACAAGTGCGATATCACCTTACAGGAGATCATCAAAACTTTGAACAGCCTCACAGAGCAGAAGACTTGTGCACCGAGTTGACCGTAACAGACATCTTTGCTGCCTCCAAGAACACAACTGAGAAGGAAACCTTCTGCAGGGCTGCGACTGTGCTCCGGCAGTTCTACAGCCACCATGAGAAGGACACTCGCTGCCTGGGTGCGACTGCACAGCAGTTCCACAGGCACAAGCAGCTGATCCGATTCCTGAAACGGCTCGACAGGAA</named-content></td></tr><tr><td align="left" rowspan="1" colspan="1">IL-12p40</td><td align="left" rowspan="1" colspan="1">301</td><td align="left" rowspan="1" colspan="1"><named-content content-type="gene">CCAACAACTTGCAGCTGAAGCCATTAAAGAATTCTCGGCAGGTGGGAGTACCCTGACACCTGGAGTACTCCACATTCCTACTTCTCCCTGACAGGTCCAGGGCAAGAGCAAGAGAGAAAAGAAAGATAGAGTCTTCACCGACCACGGTCATCTGCCGCAAAAATGCCAGCATTAGCGTGCGGGCCCAGGACCTCATCTTGGAGCGAATGGGCATCTGTGCCCTGCAGTTAGGTTCTGATCTTTGGAGGAAAAGTGGAAGATATTAAGCAAAATGTTTAAAAGACACAACGGAATAGACCCA</named-content></td></tr></tbody></table></table-wrap></sec><sec id="s2c"><title>RNA-RNA <italic>In Situ</italic> Hybridisation and Dual Labelling</title><p>This was performed essentially as described previously <xref ref-type="bibr" rid="pone.0004228-Fenhalls1">&#x0005b;28&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Fenhalls2">&#x0005b;29&#x0005d;</xref> on paraffin-embedded lung tissue.</p><p>Briefly, consecutive 5 &#x000b5;m sections were applied to RNase-free slides previously coated with aminopropyltriethoxysilane (5 &#x003bc;g/ml, Sigma Aldrich), deparaffinized in xylene, rehydrated through graded ethanols and diethyl pyrocarbonate-treated water and incubated in phosphate-buffered saline (PBS). The sections were treated with proteinase K in Tris-HCl-EDTA, washed with PBS, refixed in paraformaldehyde and acetylated in triethanolamine-acetic anhydride. The slides were then rinsed, dehydrated and air-dried before hybridization. Sections were incubated in a mixture of dextran sulphate, Tris-HCl, Denhardt's solution, EDTA, dithiothreitol, herring sperm DNA, tRNA and deionized formamide. Sections were hybridized for 18 hours in a humidified chamber at 50&#x000b0;C, washed in saline sodium citrate, incubated in Tris-HCl-NaCl containing sheep serum and then washed. Thereafter, sections were incubated with antidigoxigenin antibody conjugated to alkyline phosphatase (Boehringer Mannheim) and the signal detected with BCIP-NBT-INT (Dako). After the appearance of a brown colour slides were counterstained with Mayer's hematoxylin (Sigma Aldrich), rinsed in distilled water, mounted with Dako Faramount and viewed under a light microscope.</p><p>For dual labelling, slides were rinsed and non-specific protein blocked with milk powder and Triton-X 100 in PBS. Sections were incubated with antibody diluted in goat serum, washed and labelled with secondary biotinylated goat anti-mouse antibody diluted in goat serum and Triton-X 100. Sections were washed again, incubated with streptavidin conjugated to alkyline phosphatase, washed in PBS and incubated with a solution of fast red (Vector Laboratories). Slides were counterstained with hematoxylin and mounted with Dako Faramount.</p></sec><sec id="s2d"><title>Photography and Assessment of Slides</title><p>Images were captured using a Zeiss light microscope with light parameters optimized for the actin stained slide. These settings were kept constant in order to maintain comparability between slides. Control slides were added parallel to each staining procedure to show that the positive colour was specific and that the mRNA was not degraded (<xref ref-type="fig" rid="pone-0004228-g001">Figure 1</xref>). The number of necrotic and non-necrotic granulomas were determined by H&#x0002b;E stain. A map of each section of the granuloma was created by photographing the slides at &#x000d7;25 magnification (<xref ref-type="fig" rid="pone-0004228-g002">Figure 2</xref>). Each granuloma was subsequently numbered. The slides were then examined under the light microscope and the cytokine profile of each numbered granuloma was graded (at &#x000d7;400 magnification) on the photographic map as follows:</p><list list-type="bullet"><list-item><p>&#x0003e;75&#x00025; of cells in a granuloma positive: grade 3 positivity</p></list-item><list-item><p>25&#x00025; to 75&#x00025; of cells in a granuloma positive: grade 2 positivity</p></list-item><list-item><p>&#x0003c;25&#x00025; of cells in a granuloma positive: grade 1 positivity</p></list-item><list-item><p>no cells positive: grade 0 positivity</p></list-item></list><fig id="pone-0004228-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004228.g001</object-id><label>Figure 1</label><caption><title>Positive and negative control staining in human tissue.</title><p>Paraffin-embedded tissue was stained using ISH for mRNA expression. Negative and sense probe controls were repeated each time lung tissue was stained for cytokine expression. In the first control (A) lung granulomatous tissue was not stained with probe. The absence of brown staining proves that there was no nonspecific staining. Magnification 200&#x000d7;. In the second control (B) anti-sense probe was applied to tissue known not to produce cytokines (sarcoma). The absence of brown staining proves that there was no nonspecific staining. Magnification 400&#x000d7;. In the third control (C) granulomatous lung tissue was stained with sense probe. The absence of brown staining represents specificity. Magnification 200&#x000d7;. In the last control (D) granulomatous lung tissue was stained with the anti-sense &#x003b2;-actin probe. Brown staining indicates the presence of non-degraded mRNA. &#x003b2;-actin expression is diffusely positive. Magnification 200&#x000d7;.</p></caption><graphic xlink:href="pone.0004228.g001"/></fig><fig id="pone-0004228-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004228.g002</object-id><label>Figure 2</label><caption><title>A granuloma map used to assess the slides from patients with granumatous diseases.</title><p>This example represents the type of granuloma map used to assess the tissue biopsies of patients with pleural TB for the absence or presence of granulomas and type (necrotic or non-necrotic) of granuloma. Once the granuloma was identified, ISH was used to stain the tissue for mRNA cytokine expression. Magnification 25&#x000d7;.</p></caption><graphic xlink:href="pone.0004228.g002"/></fig></sec><sec id="s2e"><title>Statistical analysis</title><p>All granulomas were regarded as independent parameters.</p><p>Statistical analysis on samples from patients with pleural TB was performed by applying the Pearson Chi square and Spearman rank R tests to the following parameters:</p><list list-type="bullet"><list-item><p>The association between HIV serology and presence of necrosis.</p></list-item><list-item><p>The association between HIV and individual cytokines</p></list-item><list-item><p>Comparisons in association patterns between various cytokines between HIV negative and HIV positive granulomas.</p></list-item><list-item><p>The association between necrosis and individual cytokines.</p></list-item><list-item><p>Comparisons in association patterns between various cytokines between necrotic and non-necrotic granulomas.</p></list-item></list><p>In addition, to test for association between pairs of cytokines and necrosis a two-tailed Fisher's exact test was used.</p></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Demographic and clinical data</title><p>There were 2 male and 4 female TB patients in the HIV positive group with a mean age of 34.5 years compared to 5 males and 1 female with a mean age of 38 years in the HIV negative group. All patients presented with symptoms of pleuritis. All pleural biopsies were subsequently found to be culture positive for drug-sensitive <italic>Mtb</italic>.</p></sec><sec id="s3b"><title>Necrosis is more prevalent in granulomas of HIV positive patients</title><p>Of the 166 granulomas present in pleural biopsies from the 12 patients with pleural TB, 125 were from HIV negative patients and 41 from HIV positive patients. Necrosis was more prevalent in granulomas of HIV positive patients (<xref ref-type="fig" rid="pone-0004228-g003">Figure 3</xref>). In the 6 HIV positive patients, 27 (66&#x00025;) of granulomas were necrotic whereas only 21 (17&#x00025;) were necrotic in the HIV negative group (Chi-square test <italic>p</italic>&#x0003c;0.01).</p><fig id="pone-0004228-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004228.g003</object-id><label>Figure 3</label><caption><title>Necrosis and expression of mixed Th1/Th2 and Th1 responses in granulomas of pleural tuberculosis patients.</title><p>The percentage of granulomas with necrosis and expression of Th1 and Th2 cytokines were assessed microscopically. Groups include HIV positive (PLTB HIV&#x0002b;, n&#x0200a;&#x0003d;&#x0200a;6) and HIV negative (PLTB HIV&#x02212;, n&#x0200a;&#x0003d;&#x0200a;6) pleural TB patients (n&#x0200a;&#x0003d;&#x0200a;12). The percentage of necrosis is represented by solid bars, the percentage of Th1 response by clear bars and the percentage of a mixed Th1/Th2 response by striped bars. There was a significantly higher percentage of necrotic granulomas in HIV positive compared to HIV negative TB patients (Bootstrap test <italic>p</italic>&#x0003c;0.01).</p></caption><graphic xlink:href="pone.0004228.g003"/></fig></sec><sec id="s3c"><title>Cytokine expression is upregulated in necrotic granulomas and granulomas of HIV positive TB patients</title><p>Pleural biopsy tissue was examined for IL-12, IFN-&#x003b3;, TNF-&#x003b1; and IL-4 mRNA expression using <italic>in situ</italic> hybridization (ISH). Representative images illustrate the presence of both Th1 and Th2 cytokine mRNA expression, all of which were more prevalent in necrotic granulomas (<xref ref-type="fig" rid="pone-0004228-g004">Figure 4</xref>). The extent of Th1 and mixed Th1/Th2 responses was not different between granulomas of HIV positive and negative TB patients (<xref ref-type="fig" rid="pone-0004228-g003">Figure 3</xref>).</p><fig id="pone-0004228-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004228.g004</object-id><label>Figure 4</label><caption><title>Cytokine mRNA expression in HIV positive and negative pleural tuberculous granulomas.</title><p>Paraffin-embedded tissue was stained using ISH for mRNA expression. Representative sections of pleural needle biopsies from HIV positive (A&#x02013;D) patients are shown. (A) Staining with the anti-sense IL-12 probe shows that over 75&#x00025; of cells are positive for IL-12 mRNA expression. Magnification 400&#x000d7;. (B) Staining with the anti-sense IFN-&#x003b3; probe shows that over 75&#x00025; of cells are positive for IFN-&#x003b3; mRNA expression. Magnification 400&#x000d7;. (C) Staining with the anti-sense TNF-&#x003b1; probe shows that over 75&#x00025; of cells are positive for TNF-&#x003b1; mRNA expression. Magnification 400&#x000d7;. (D) Staining with the anti-sense IL-4 probe shows that over 75&#x00025; of cells are positive for IL-4 mRNA expression. Magnification 400&#x000d7;. Representative sections of pleural needle biopsies from HIV negative (E&#x02013;H) patients are shown. (E) Staining with the anti-sense IL-12 probe shows that 25&#x00025;&#x02013;75&#x00025; of cells are positive for IL-12 mRNA expression. Magnification 100&#x000d7;. (F) Staining with the anti-sense IFN-&#x003b3; probe shows that 25&#x00025;&#x02013;75&#x00025; of cells are positive for IFN-&#x003b3; mRNA expression. Magnification 100&#x000d7;. (G) Staining with the anti-sense TNF-&#x003b1; probe shows that 25&#x00025;&#x02013;75&#x00025; of cells are positive for TNF-&#x003b1; mRNA expression. Magnification 100&#x000d7;. (H) Staining with the anti-sense IL-4 probe shows that less than 25&#x00025; of cells are positive for IL-4 mRNA expression. Magnification 100&#x000d7;.</p></caption><graphic xlink:href="pone.0004228.g004"/></fig><p>While the presence of necrosis did not significantly influence the grade of IL-12 mRNA positivity, IFN-&#x003b3;, TNF-&#x003b1; and IL-4 mRNA expression were markedly upregulated in necrotic granulomas (<xref ref-type="table" rid="pone-0004228-t002">Table 2</xref>). Similarly, IL-12, IFN-&#x003b3;, TNF-&#x003b1; and IL-4 mRNA expressions were markedly upregulated in both necrotic and non-necrotic granulomas of HIV positive TB patients (<xref ref-type="table" rid="pone-0004228-t003">Table 3</xref>).</p><table-wrap id="pone-0004228-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004228.t002</object-id><label>Table 2</label><caption><title>The percentage of necrotic and non-necrotic granulomas positive for specific cytokines in patients with pleural tuberculosis.</title></caption><graphic id="pone-0004228-t002-2" xlink:href="pone.0004228.t002"/><table frame="hsides" rules="groups" alternate-form-of="pone-0004228-t002-2"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="4" align="left" rowspan="1">Cytokine expression grade Non-necrotic granulomas</td><td colspan="4" align="left" rowspan="1">Cytokine expression grade Necrotic granulomas</td><td align="left" rowspan="1" colspan="1">Chi-square test</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">IL-12</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">31&#x00025;</td><td align="left" rowspan="1" colspan="1">44&#x00025;</td><td align="left" rowspan="1" colspan="1">25&#x00025;</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">23&#x00025;</td><td align="left" rowspan="1" colspan="1">54&#x00025;</td><td align="left" rowspan="1" colspan="1">23&#x00025;</td><td align="left" rowspan="1" colspan="1"><italic>p</italic>&#x0200a;&#x0003d;&#x0200a;0.50</td></tr><tr><td align="left" rowspan="1" colspan="1">IFN-&#x003b3;</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">48&#x00025;</td><td align="left" rowspan="1" colspan="1">35&#x00025;</td><td align="left" rowspan="1" colspan="1">17&#x00025;</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">35&#x00025;</td><td align="left" rowspan="1" colspan="1">25&#x00025;</td><td align="left" rowspan="1" colspan="1">40&#x00025;</td><td align="left" rowspan="1" colspan="1"><italic>p</italic>&#x0200a;&#x0003d;&#x0200a;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">TNF-&#x003b1;</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">35&#x00025;</td><td align="left" rowspan="1" colspan="1">42&#x00025;</td><td align="left" rowspan="1" colspan="1">24&#x00025;</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">17&#x00025;</td><td align="left" rowspan="1" colspan="1">19&#x00025;</td><td align="left" rowspan="1" colspan="1">64&#x00025;</td><td align="left" rowspan="1" colspan="1"><italic>p</italic>&#x0003c;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-4</td><td align="left" rowspan="1" colspan="1">3&#x00025;</td><td align="left" rowspan="1" colspan="1">50&#x00025;</td><td align="left" rowspan="1" colspan="1">26&#x00025;</td><td align="left" rowspan="1" colspan="1">21&#x00025;</td><td align="left" rowspan="1" colspan="1">6&#x00025;</td><td align="left" rowspan="1" colspan="1">17&#x00025;</td><td align="left" rowspan="1" colspan="1">42&#x00025;</td><td align="left" rowspan="1" colspan="1">35&#x00025;</td><td align="left" rowspan="1" colspan="1"><italic>p</italic>&#x0003c;0.01</td></tr></tbody></table><table-wrap-foot><fn id="nt101"><label/><p>The presence of IL-12, IFN-&#x003b3;, TNF-&#x003b1; and IL-4 positive cells was assessed by <italic>in situ</italic> hybridisation in granulomas from pleural biopsies. Positivity was graded according to the total number of cells staining positive in a specific granuloma (&#x0003c;25&#x00025;, grade 1; 25&#x02013;75&#x00025;, grade 2 and &#x0003e;75&#x00025;, grade 3).</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0004228-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004228.t003</object-id><label>Table 3</label><caption><title>The percentage of granulomas positive for specific cytokines in HIV negative and HIV positive pleural tuberculosis patients.</title></caption><graphic id="pone-0004228-t003-3" xlink:href="pone.0004228.t003"/><table frame="hsides" rules="groups" alternate-form-of="pone-0004228-t003-3"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="4" align="left" rowspan="1">Cytokine expression grade HIV negative granulomas</td><td colspan="4" align="left" rowspan="1">Cytokine expression grade HIV positive granulomas</td><td align="left" rowspan="1" colspan="1">Chi-square test</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">IL-12</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">31&#x00025;</td><td align="left" rowspan="1" colspan="1">46&#x00025;</td><td align="left" rowspan="1" colspan="1">23&#x00025;</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">20&#x00025;</td><td align="left" rowspan="1" colspan="1">49&#x00025;</td><td align="left" rowspan="1" colspan="1">31&#x00025;</td><td align="left" rowspan="1" colspan="1"><italic>p</italic>&#x0200a;&#x0003d;&#x0200a;0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">IFN&#x003b3;</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">50&#x00025;</td><td align="left" rowspan="1" colspan="1">30&#x00025;</td><td align="left" rowspan="1" colspan="1">20&#x00025;</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">26&#x00025;</td><td align="left" rowspan="1" colspan="1">37&#x00025;</td><td align="left" rowspan="1" colspan="1">37&#x00025;</td><td align="left" rowspan="1" colspan="1"><italic>p</italic>&#x0200a;&#x0003d;&#x0200a;0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">TNF&#x003b1;</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">31&#x00025;</td><td align="left" rowspan="1" colspan="1">42&#x00025;</td><td align="left" rowspan="1" colspan="1">27&#x00025;</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">24&#x00025;</td><td align="left" rowspan="1" colspan="1">15&#x00025;</td><td align="left" rowspan="1" colspan="1">61&#x00025;</td><td align="left" rowspan="1" colspan="1"><italic>p</italic>&#x0003c;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-4</td><td align="left" rowspan="1" colspan="1">2&#x00025;</td><td align="left" rowspan="1" colspan="1">46&#x00025;</td><td align="left" rowspan="1" colspan="1">26&#x00025;</td><td align="left" rowspan="1" colspan="1">26&#x00025;</td><td align="left" rowspan="1" colspan="1">7&#x00025;</td><td align="left" rowspan="1" colspan="1">24&#x00025;</td><td align="left" rowspan="1" colspan="1">46&#x00025;</td><td align="left" rowspan="1" colspan="1">23&#x00025;</td><td align="left" rowspan="1" colspan="1"><italic>p</italic>&#x0200a;&#x0003d;&#x0200a;0.02</td></tr></tbody></table><table-wrap-foot><fn id="nt102"><label/><p>IL-12, IFN-&#x003b3;, TNF-&#x003b1; and IL-4 mRNA expression was examined by <italic>in situ</italic> hybridisation on granulomas from pleural biopsies. Positivity was graded according to the total number of cells staining positive in a specific granuloma (&#x0003c;25&#x00025;, grade 1; 25&#x02013;75&#x00025;, grade 2 and &#x0003e;75&#x00025;, grade 3).</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3d"><title>Cytokine expression in necrotic granulomas and granulomas of HIV positive TB patients is dysregulated</title><p>There was a strong positive correlation between all cytokines expressed in non-necrotic granulomas and granulomas from HIV negative TB patients (<xref ref-type="table" rid="pone-0004228-t004">Table 4</xref>). By contrast, expression of fewer cytokines in necrotic granulomas were correlated and cytokines expressed in granulomas of HIV positive TB patients were not correlated at all, with the exception of IL-12 and TNF-&#x003b1; whose expression was negatively correlated. It is interesting to note that IL-4 expression, representing a Th2 response, was correlated to the expressions of the Th1 cytokines IL-12, IFN-&#x003b3; and TNF-&#x003b1;.</p><table-wrap id="pone-0004228-t004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004228.t004</object-id><label>Table 4</label><caption><title>Spearman rank R correlation for cytokines in granulomas of pleural TB patients.</title></caption><graphic id="pone-0004228-t004-4" xlink:href="pone.0004228.t004"/><table frame="hsides" rules="groups" alternate-form-of="pone-0004228-t004-4"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Cytokines</td><td colspan="4" align="left" rowspan="1">Type of Granuloma</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Non-necrotic</td><td align="left" rowspan="1" colspan="1">Necrotic</td><td align="left" rowspan="1" colspan="1">HIV negative</td><td align="left" rowspan="1" colspan="1">HIV positive</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">IL-12 vs IFN-&#x003b3;</td><td align="left" rowspan="1" colspan="1">0.49 (0.00)&#x0002a;</td><td align="left" rowspan="1" colspan="1">0.32 (0.83)</td><td align="left" rowspan="1" colspan="1">0.49 (0.00)&#x0002a;</td><td align="left" rowspan="1" colspan="1">&#x02212;0.16 (0.30)</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-12 vs TNF-&#x003b1;</td><td align="left" rowspan="1" colspan="1">0.44 (0.00)&#x0002a;</td><td align="left" rowspan="1" colspan="1">&#x02212;0.17 (0.24)</td><td align="left" rowspan="1" colspan="1">0.49 (0.00)&#x0002a;</td><td align="left" rowspan="1" colspan="1">&#x02212;0.45 (0.003)&#x0002a;</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-12 vs IL-4</td><td align="left" rowspan="1" colspan="1">0.39 (0.00)&#x0002a;</td><td align="left" rowspan="1" colspan="1">0.21 (0.15)</td><td align="left" rowspan="1" colspan="1">0.47 (0.00)&#x0002a;</td><td align="left" rowspan="1" colspan="1">&#x02212;0.04 (0.80)</td></tr><tr><td align="left" rowspan="1" colspan="1">IFN-&#x003b3; vs TNF-&#x003b1;</td><td align="left" rowspan="1" colspan="1">0.58 (0.00)&#x0002a;</td><td align="left" rowspan="1" colspan="1">0.63 (0.00)&#x0002a;</td><td align="left" rowspan="1" colspan="1">0.66 (0.00)&#x0002a;</td><td align="left" rowspan="1" colspan="1">0.38 (0.01)</td></tr><tr><td align="left" rowspan="1" colspan="1">IFN-&#x003b3; vs IL-4</td><td align="left" rowspan="1" colspan="1">0.33 (0.0003)&#x0002a;</td><td align="left" rowspan="1" colspan="1">0.65 (0.00)&#x0002a;</td><td align="left" rowspan="1" colspan="1">0.52 (0.00)&#x0002a;</td><td align="left" rowspan="1" colspan="1">0.22 (0.16)</td></tr><tr><td align="left" rowspan="1" colspan="1">TNF-&#x003b1; vs IL-4</td><td align="left" rowspan="1" colspan="1">0.46 (0.00)&#x0002a;</td><td align="left" rowspan="1" colspan="1">0.34 (0.02)&#x0002a;</td><td align="left" rowspan="1" colspan="1">0.59 (0.00)&#x0002a;</td><td align="left" rowspan="1" colspan="1">0.08 (0.60)</td></tr></tbody></table><table-wrap-foot><fn id="nt103"><label/><p>IL-12, IFN-&#x003b3;, TNF-&#x003b1; and IL-4 mRNA expression was examined by <italic>in situ</italic> hybridisation on granulomas from pleural biopsies. Statistically significant correlations are noted with &#x0002a; with <italic>p</italic>-values in brackets.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="s4"><title>Discussion</title><p>This work characterised cytokine expression at the site of disease during the granulomatous response in pleural TB, in HIV infected and uninfected individuals and in necrotic and non-necrotic granulomas. Patients with pleural TB presented with a mixed Th1/Th2 profile and this contradicts a characterisation of HIV negative pleural TB as Th1 dominant <xref ref-type="bibr" rid="pone.0004228-Jalapathy1">&#x0005b;32&#x0005d;</xref>. The main findings were a strong presence of TNF-&#x003b1; positive cells in necrotic granulomas, particularly in granulomas from HIV positive patients, where increased necrosis has previously been described <xref ref-type="bibr" rid="pone.0004228-Lucas1">&#x0005b;33&#x0005d;</xref>. Although we found high levels of TNF-&#x003b1; in our HIV positive TB patients, Noronha <italic>et al</italic> found the opposite <xref ref-type="bibr" rid="pone.0004228-deNoronha1">&#x0005b;34&#x0005d;</xref>. This discrepancy may be due to different stages of immunosuppression in the two studies. In the present study granuloma morphology was intact, which suggests relative immune competence, whereas poorly formed or absence of granulomas, as seen in the Noronha study, may indicate advanced immunosuppression <xref ref-type="bibr" rid="pone.0004228-Lucas1">&#x0005b;33&#x0005d;</xref>. However, the presence of high expression levels of TNF-&#x003b1; mRNA as seen in our study does not necessarily equate to increased presence of TNF-&#x003b1; protein and may even be representative of a failed attempt to induce cytokine production.</p><p>The investigation of immune responses at the site of disease is extremely valuable because cytokine responses do not necessarily mimic those found in the peripheral blood <xref ref-type="bibr" rid="pone.0004228-Barnes1">&#x0005b;19&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Barnes2">&#x0005b;35&#x0005d;</xref>. This may be due to a redistribution of antigen specific cells to the site of disease (compartmentalization), where their effects on the eventual outcome of infection may be crucial.</p><p>Although the presence of TNF-&#x003b1; is beneficial in the immune response against <italic>Mtb</italic>, and is necessary for granuloma formation, it does cause immunopathology such as caseous necrosis <xref ref-type="bibr" rid="pone.0004228-Bekker1">&#x0005b;23&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Roach1">&#x0005b;36&#x0005d;</xref>. This is probably a consequence of apoptosis of infected macrophages, epithelioid cells and activated T cells within the granuloma <xref ref-type="bibr" rid="pone.0004228-Fayyazi1">&#x0005b;37&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Keane1">&#x0005b;38&#x0005d;</xref> as has been shown in human TB <xref ref-type="bibr" rid="pone.0004228-Fayyazi1">&#x0005b;37&#x0005d;</xref>. The link between the apoptotic activity of TNF-&#x003b1; <xref ref-type="bibr" rid="pone.0004228-Carswell1">&#x0005b;39&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Rath1">&#x0005b;40&#x0005d;</xref> and the formation of caseous necrosis may be due to secondary necrosis (reviewed in <xref ref-type="bibr" rid="pone.0004228-Viorritto1">&#x0005b;41&#x0005d;</xref>). Whereas apoptosis is a strictly regulated process, and leads to the containment of cell debris, necrosis is unregulated and results in the spilling of intracellular contents. The processes may become linked when cell uptake is disrupted and the rate of cell death exceeds the rate at which macrophages are able to phagocytose apoptotic material. This leads to the impaired uptake of apoptotic cells and during this delay necrosis may develop. Thus, although primary necrosis may be very rare during lung inflammation due to <italic>Mtb</italic> infection, secondary necrosis may be common <xref ref-type="bibr" rid="pone.0004228-RydellTormanen1">&#x0005b;42&#x0005d;</xref>. This mechanism may be compounded by the <italic>Mtb</italic>-mediated lysis of macrophages which triggers the macrophage cell death pathway. This not only allows dissemination of the bacilli but also contributes to the formation of necrotic lesions <xref ref-type="bibr" rid="pone.0004228-Lee1">&#x0005b;43&#x0005d;</xref>.</p><p>Although apoptosis is an important host defence mechanism to deprive <italic>Mtb</italic> of its intracellular sanctuary and inhibit its growth and survival <xref ref-type="bibr" rid="pone.0004228-Fairbairn1">&#x0005b;44&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Hirsch1">&#x0005b;45&#x0005d;</xref>, it also facilitates mycobacterial dissemination and may therefore be orchestrated by the bacillus itself <xref ref-type="bibr" rid="pone.0004228-Das1">&#x0005b;46&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Fayyazi1">&#x0005b;37&#x0005d;</xref>. It is unclear whether apoptosis favours the host or the pathogen as impaired apoptosis also maintains granulomas by preventing T cell clonal deletion <xref ref-type="bibr" rid="pone.0004228-Uhal1">&#x0005b;47&#x0005d;</xref>. The viability of <italic>Mtb</italic> after Fas ligand or TNF-&#x003b1; mediated apoptosis of immune cells is controversial with both reduced and unchanged bacterial numbers reported <xref ref-type="bibr" rid="pone.0004228-Condos1">&#x0005b;48&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Tan1">&#x0005b;49&#x0005d;</xref>.</p><p>Previous studies that investigated correlations between granuloma histology and cytokine mRNA expression <xref ref-type="bibr" rid="pone.0004228-Fenhalls1">&#x0005b;28&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Fenhalls2">&#x0005b;29&#x0005d;</xref> suggested that the presence of IL-4 may not be an indicator of poor prognosis in pulmonary TB patients but may rather be an integral feature of tuberculous granuloma formation and may limit tissue damage. Their results showed that IL-4 positive granulomas tended to be non-necrotic whereas all necrotic granulomas were TNF-&#x003b1; positive and negative or weakly positive for IL-4 and IFN-&#x003b3;. Although we cannot extrapolate from these findings to a causative relationship between TNF-&#x003b1; and necrosis, it appears likely that TNF-&#x003b1; may promote necrosis. The caseous necrosis appears to be a consequence of apoptosis of infected macrophages and activated T cells and TNF-&#x003b1; is a known inducer of apoptosis <xref ref-type="bibr" rid="pone.0004228-Carswell1">&#x0005b;39&#x0005d;</xref>. An essential role for IL-12 and IFN-&#x003b3; in protective immunity to mycobacterial infection has been previously described <xref ref-type="bibr" rid="pone.0004228-Gately1">&#x0005b;50&#x0005d;</xref>. Furthermore individuals with defective IL-12 or IFN-&#x003b3; receptors are susceptible to disseminated mycobacterial infection <xref ref-type="bibr" rid="pone.0004228-Jouanguy1">&#x0005b;51&#x0005d;</xref> and decreased IFN-&#x003b3; production by peripheral blood mononuclear leukocytes has been shown to correlate with decreased IL-12 receptor subunits B1 and B2 in patients with tuberculosis <xref ref-type="bibr" rid="pone.0004228-Zhang1">&#x0005b;52&#x0005d;</xref>.</p><p>The cytokine pattern observed in patients with pleural TB reflects a model by Wigginton and Kirscher <xref ref-type="bibr" rid="pone.0004228-Wigginton1">&#x0005b;53&#x0005d;</xref> that was designed to predict CMI during human infection with <italic>Mtb</italic>. We found increased IFN-&#x003b3; expression in necrotic granulomas and, although, like TNF-&#x003b1;, it is crucial in defence against <italic>Mtb</italic>, high effector cytokine levels during chronic phases of disease may contribute to immunopathology, especially in the presence of high TNF-&#x003b1; expression <xref ref-type="bibr" rid="pone.0004228-Dorman1">&#x0005b;54&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Roach1">&#x0005b;36&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Wigginton1">&#x0005b;53&#x0005d;</xref>. The strong correlation between TNF-&#x003b1; and IFN-&#x003b3; expression and HIV positivity supports the concept that cytokine overproduction may represent an attempt to compensate for the failure of other CD4 effector T cell functions, including proper granuloma formation and the antigen-specific activation of macrophages <xref ref-type="bibr" rid="pone.0004228-Barnes1">&#x0005b;19&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Subramanyam1">&#x0005b;55&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Wigginton1">&#x0005b;53&#x0005d;</xref>.</p><p>By contrast, non-necrotic granulomas with a high number of IL-12 positive cells also expressed high levels of IL-4 and this was not associated with necrosis presumably because Th2 cytokines mediate local tissue inflammation and necrosis through their effect on TNF-&#x003b1; induced cytotoxicity <xref ref-type="bibr" rid="pone.0004228-HernandezPando1">&#x0005b;56&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Muller1">&#x0005b;57&#x0005d;</xref>. IL-4 may therefore provide a regulatory mechanism to antagonise necrosis-inducing factors but in doing so may also shift infection from latency to disease <xref ref-type="bibr" rid="pone.0004228-Wigginton1">&#x0005b;53&#x0005d;</xref>. This is in contrast to other studies which have found that IL-4 works in synergy with TNF-&#x003b1; to increase necrosis (reviewed in <xref ref-type="bibr" rid="pone.0004228-Dheda1">&#x0005b;58&#x0005d;</xref>). We did not measure IL-4's natural antagonistic splice variant, IL-4&#x003b4;2, which has been found to be expressed in the lungs of TB and TB-HIV co-infected patients <xref ref-type="bibr" rid="pone.0004228-Dheda2">&#x0005b;59&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Dheda3">&#x0005b;60&#x0005d;</xref>. It is therefore possible that the upregulation of IL-4 seen in non-necrotic granulomas may be due, in part, to an upregulation of the splice variant. However, we still believe that IL-4 plays a predominant role because an upregulation of the splice variant would have facilitated an increase in inflammation and necrosis. Dheda <italic>et al</italic><xref ref-type="bibr" rid="pone.0004228-Dheda3">&#x0005b;60&#x0005d;</xref> have also highlighted that, during infection with HIV, the switch from a Th1 to a Th2 response may not necessary be responsible for the progression to AIDS in the absence of opportunistic infections. However, when co-infected with TB, IL-4 expression is upregulated and this may allow an increase in viral replication.</p><p>Interestingly very few necrotic granulomas expressed a high level of IFN-&#x003b3;-positive cells in the presence of high IL-12 expression. This may suggest a breakdown in the regulatory function of IL-12 which usually regulates the expression of IFN-&#x003b3; <xref ref-type="bibr" rid="pone.0004228-Hart1">&#x0005b;61&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004228-Trinchieri1">&#x0005b;62&#x0005d;</xref>. Non-necrotic granulomas tended to express low levels of all cytokines which suggests that a lower cytokine presence is less destructive.</p><p>In summary, intracellular bacteria that can survive within macrophages lead to granuloma formation, which benefits the host by controlling local and systemic dissemination of pathogens but facilitates destructive pulmonary pathology. In TB, this manifests as caseous necrosis with tissue destruction and subsequent fibrosis. This facilitates disease transmission and therefore blocking any mechanism responsible for necrosis would also limit person-to-person disease transfer <xref ref-type="bibr" rid="pone.0004228-Dheda1">&#x0005b;58&#x0005d;</xref>. High levels of TNF-&#x003b1; suggests a poor prognosis in TB because it is associated with necrosis and dysregulated granuloma formation. TNF-&#x003b1; is required for granuloma formation in order to contain and/or remove the antigen but its continued presence results in the development of immunopathology as reviewed by Dheda <italic>et al</italic><xref ref-type="bibr" rid="pone.0004228-Dheda1">&#x0005b;58&#x0005d;</xref>. IL-4 may present an integral feature of immune regulation as a pure Th1 response is not necessarily beneficial during granulomatous disease but instead the Th1/Th2 ratio should be finely balanced depending on the stage of disease. An early Th1 response is necessary to clear the antigen during the acute stage of infection whereas during chronic disease an abrogation of the Th1 response is necessary to minimise tissue damage caused by necrosis and fibrosis.</p><p>In conclusion, this study reports on the expression of Th1 and Th2 immune phenotypes at the site of disease in TB pleuritis. It is shown that HIV positivity results in increased necrosis associated with elevated TNF-&#x003b1; mRNA expression. Future studies should also investigate the expression of other cytokines, chemokines and their receptors to allow a more comprehensive understanding of factors that determine the fine balance between protective and immunopathological responses after infection with <italic>Mtb</italic>.</p></sec></body><back><ack><p>The authors would like to acknowledge Dr Martin Kidd for the statistical analyses.</p></ack><ref-list><title>References</title><ref id="pone.0004228-Algood1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Algood</surname><given-names>HM</given-names></name><name><surname>Chan</surname><given-names>J</given-names></name><name><surname>Flynn</surname><given-names>JL</given-names></name></person-group><year>2003</year><article-title>Chemokines and tuberculosis.</article-title><source>Cytokine Growth Factor Rev</source><volume>14</volume><fpage>467</fpage><lpage>477</lpage><pub-id pub-id-type="pmid">14563349</pub-id></citation></ref><ref id="pone.0004228-Thurlbeck1"><label>2</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Thurlbeck</surname><given-names>W</given-names></name><name><surname>Churg</surname><given-names>A</given-names></name></person-group><year>1995</year><source>Chapter 13: Pathology of the Lung</source><publisher-name>Thieme Medical Publishers</publisher-name><fpage>234</fpage></citation></ref><ref id="pone.0004228-Hasleton1"><label>3</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Hasleton</surname><given-names>PS</given-names></name></person-group><year>1996</year><source>Chapter 7: Spencer's Pathology of the Lung</source><publisher-name>Mc Graw-Hill</publisher-name><fpage>227</fpage></citation></ref><ref id="pone.0004228-Ellner1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ellner</surname><given-names>JJ</given-names></name><name><surname>Barnes</surname><given-names>PF</given-names></name><name><surname>Wallis</surname><given-names>RS</given-names></name><name><surname>Modlin</surname><given-names>RL</given-names></name></person-group><year>1988</year><article-title>The immunology of tuberculous pleurisy.</article-title><source>Semin Respir Infect</source><volume>3</volume><fpage>335</fpage><lpage>342</lpage><pub-id pub-id-type="pmid">2463656</pub-id></citation></ref><ref id="pone.0004228-Roper1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roper</surname><given-names>WH</given-names></name><name><surname>Waring</surname><given-names>JJ</given-names></name></person-group><year>1955</year><article-title>Primary serofibrinous pleural effusion in military personnel.</article-title><source>Am Rev Tuberc</source><volume>71</volume><fpage>616</fpage><lpage>634</lpage><pub-id pub-id-type="pmid">14361976</pub-id></citation></ref><ref id="pone.0004228-Saunders1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saunders</surname><given-names>BM</given-names></name><name><surname>Cooper</surname><given-names>AM</given-names></name></person-group><year>2000</year><article-title>Restraining mycobacteria: role of granulomas in mycobacterial infections.</article-title><source>Immunol Cell Biol</source><volume>78</volume><fpage>334</fpage><lpage>341</lpage><pub-id pub-id-type="pmid">10947857</pub-id></citation></ref><ref id="pone.0004228-Braun1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Braun</surname><given-names>MM</given-names></name><name><surname>Badi</surname><given-names>N</given-names></name><name><surname>Ryder</surname><given-names>RW</given-names></name><name><surname>Baende</surname><given-names>E</given-names></name><name><surname>Mukadi</surname><given-names>Y</given-names></name><etal/></person-group><year>1991</year><article-title>A retrospective cohort study of the risk of tuberculosis among women of childbearing age with HIV infection in Zaire.</article-title><source>Am Rev Respir Dis</source><volume>143</volume><fpage>501</fpage><lpage>504</lpage><pub-id pub-id-type="pmid">2001057</pub-id></citation></ref><ref id="pone.0004228-Schluger1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schluger</surname><given-names>NW</given-names></name></person-group><year>2001</year><article-title>Recent advances in our understanding of human host responses to tuberculosis.</article-title><source>Respir Res</source><volume>2</volume><fpage>157</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">11686880</pub-id></citation></ref><ref id="pone.0004228-Clerici1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clerici</surname><given-names>M</given-names></name><name><surname>Shearer</surname><given-names>GM</given-names></name></person-group><year>1993</year><article-title>A TH1&#x02013;&#x0003e;TH2 switch is a critical step in the etiology of HIV infection.</article-title><source>Immunol Today</source><volume>14</volume><fpage>107</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">8096699</pub-id></citation></ref><ref id="pone.0004228-Maggi1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maggi</surname><given-names>E</given-names></name><name><surname>Mazzetti</surname><given-names>M</given-names></name><name><surname>Ravina</surname><given-names>A</given-names></name><name><surname>Annunziato</surname><given-names>F</given-names></name><name><surname>De Carli</surname><given-names>M</given-names></name><etal/></person-group><year>1994</year><article-title>Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells.</article-title><source>Science</source><volume>265</volume><fpage>244</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">8023142</pub-id></citation></ref><ref id="pone.0004228-Vyakarnam1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vyakarnam</surname><given-names>A</given-names></name><name><surname>Matear</surname><given-names>PM</given-names></name><name><surname>Martin</surname><given-names>SJ</given-names></name><name><surname>Wagstaff</surname><given-names>M</given-names></name></person-group><year>1995</year><article-title>Th1 cells specific for HIV-1 gag p24 are less efficient than Th0 cells in supporting HIV replication, and inhibit virus replication in Th0 cells.</article-title><source>Immunology</source><volume>86</volume><fpage>85</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">7590887</pub-id></citation></ref><ref id="pone.0004228-Imperiali1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Imperiali</surname><given-names>FG</given-names></name><name><surname>Zaninoni</surname><given-names>A</given-names></name><name><surname>La Maestra</surname><given-names>L</given-names></name><name><surname>Tarsia</surname><given-names>P</given-names></name><name><surname>Blasi</surname><given-names>F</given-names></name><etal/></person-group><year>2001</year><article-title>Increased Mycobacterium tuberculosis growth in HIV-1-infected human macrophages: role of tumour necrosis factor-alpha.</article-title><source>Clin Exp Immunol</source><volume>123</volume><fpage>435</fpage><lpage>442</lpage><pub-id pub-id-type="pmid">11298131</pub-id></citation></ref><ref id="pone.0004228-Lawn1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lawn</surname><given-names>SD</given-names></name><name><surname>Butera</surname><given-names>ST</given-names></name><name><surname>Folks</surname><given-names>TM</given-names></name></person-group><year>2001</year><article-title>Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection.</article-title><source>Clin Microbiol Rev</source><volume>14</volume><fpage>753</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">11585784</pub-id></citation></ref><ref id="pone.0004228-Oyaizu1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oyaizu</surname><given-names>N</given-names></name><name><surname>Chirmule</surname><given-names>N</given-names></name><name><surname>Kalyanaraman</surname><given-names>VS</given-names></name><name><surname>Hall</surname><given-names>WW</given-names></name><name><surname>Pahwa</surname><given-names>R</given-names></name><etal/></person-group><year>1990</year><article-title>Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4&#x0002b; T lymphocytes by inhibiting interleukin 2 mRNA.</article-title><source>Proc Natl Acad Sci USA</source><volume>87</volume><fpage>2379</fpage><lpage>2383</lpage><pub-id pub-id-type="pmid">2315327</pub-id></citation></ref><ref id="pone.0004228-Polyak1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Polyak</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Hirsch</surname><given-names>D</given-names></name><name><surname>George</surname><given-names>I</given-names></name><name><surname>Hershberg</surname><given-names>R</given-names></name><etal/></person-group><year>1997</year><article-title>Impaired class II expression and antigen uptake in monocytic cells after HIV-1 infection.</article-title><source>J Immunol</source><volume>159</volume><fpage>2177</fpage><lpage>2188</lpage><pub-id pub-id-type="pmid">9278305</pub-id></citation></ref><ref id="pone.0004228-Mukadi1"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mukadi</surname><given-names>Y</given-names></name><name><surname>Perriens</surname><given-names>JH</given-names></name><name><surname>St Louis</surname><given-names>ME</given-names></name><name><surname>Brown</surname><given-names>C</given-names></name><name><surname>Prignot</surname><given-names>J</given-names></name><etal/></person-group><year>1993</year><article-title>Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire.</article-title><source>Lancet</source><volume>342</volume><fpage>143</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">8101257</pub-id></citation></ref><ref id="pone.0004228-Garrait1"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garrait</surname><given-names>V</given-names></name><name><surname>Cadranel</surname><given-names>J</given-names></name><name><surname>Esvant</surname><given-names>H</given-names></name><name><surname>Herry</surname><given-names>I</given-names></name><name><surname>Morinet</surname><given-names>P</given-names></name><etal/></person-group><year>1997</year><article-title>Tuberculosis generates a microenvironment enhancing the productive infection of local lymphocytes by HIV.</article-title><source>J Immunol</source><volume>159</volume><fpage>2824</fpage><lpage>2830</lpage><pub-id pub-id-type="pmid">9300705</pub-id></citation></ref><ref id="pone.0004228-Goletti1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goletti</surname><given-names>D</given-names></name><name><surname>Weissman</surname><given-names>D</given-names></name><name><surname>Jackson</surname><given-names>RW</given-names></name><name><surname>Collins</surname><given-names>F</given-names></name><name><surname>Kinter</surname><given-names>A</given-names></name><etal/></person-group><year>1998</year><article-title>The in vitro induction of human immunodeficiency virus (HIV) replication in purified protein derivative-positive HIV-infected persons by recall antigen response to Mycobacterium tuberculosis is the result of a balance of the effects of endogenous interleukin-2 and proinflammatory and antiinflammatory cytokines.</article-title><source>J Infect Dis</source><volume>177</volume><fpage>1332</fpage><lpage>1338</lpage><pub-id pub-id-type="pmid">9593021</pub-id></citation></ref><ref id="pone.0004228-Barnes1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barnes</surname><given-names>PF</given-names></name><name><surname>Fong</surname><given-names>SJ</given-names></name><name><surname>Brennan</surname><given-names>PJ</given-names></name><name><surname>Twomey</surname><given-names>PE</given-names></name><name><surname>Mazumder</surname><given-names>A</given-names></name><etal/></person-group><year>1990</year><article-title>Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis.</article-title><source>J Immunol</source><volume>145</volume><fpage>149</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">2113553</pub-id></citation></ref><ref id="pone.0004228-Flynn1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>JL</given-names></name><name><surname>Chan</surname><given-names>J</given-names></name><name><surname>Triebold</surname><given-names>KJ</given-names></name><name><surname>Dalton</surname><given-names>DK</given-names></name><name><surname>Stewart</surname><given-names>TA</given-names></name><etal/></person-group><year>1993</year><article-title>An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.</article-title><source>J Exp Med</source><volume>178</volume><fpage>2249</fpage><lpage>2254</lpage><pub-id pub-id-type="pmid">7504064</pub-id></citation></ref><ref id="pone.0004228-Flynn2"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>JL</given-names></name><name><surname>Goldstein</surname><given-names>MM</given-names></name><name><surname>Chan</surname><given-names>J</given-names></name><name><surname>Triebold</surname><given-names>KJ</given-names></name><name><surname>Pfeffer</surname><given-names>K</given-names></name><etal/></person-group><year>1995</year><article-title>Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice.</article-title><source>Immunity</source><volume>2</volume><fpage>561</fpage><lpage>572</lpage><pub-id pub-id-type="pmid">7540941</pub-id></citation></ref><ref id="pone.0004228-Rhodes1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rhodes</surname><given-names>SG</given-names></name><name><surname>Palmer</surname><given-names>N</given-names></name><name><surname>Graham</surname><given-names>SP</given-names></name><name><surname>Bianco</surname><given-names>AE</given-names></name><name><surname>Hewinson</surname><given-names>RG</given-names></name><etal/></person-group><year>2000</year><article-title>Distinct response kinetics of gamma interferon and interleukin-4 in bovine tuberculosis.</article-title><source>Infect Immun</source><volume>68</volume><fpage>5393</fpage><lpage>5400</lpage><pub-id pub-id-type="pmid">10948169</pub-id></citation></ref><ref id="pone.0004228-Bekker1"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bekker</surname><given-names>LG</given-names></name><name><surname>Moreira</surname><given-names>AL</given-names></name><name><surname>Bergtold</surname><given-names>A</given-names></name><name><surname>Freeman</surname><given-names>S</given-names></name><name><surname>Ryffel</surname><given-names>B</given-names></name><etal/></person-group><year>2000</year><article-title>Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent.</article-title><source>Infect Immun</source><volume>68</volume><fpage>6954</fpage><lpage>6961</lpage><pub-id pub-id-type="pmid">11083819</pub-id></citation></ref><ref id="pone.0004228-Ehlers1"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ehlers</surname><given-names>S</given-names></name><name><surname>Kutsch</surname><given-names>S</given-names></name><name><surname>Ehlers</surname><given-names>EM</given-names></name><name><surname>Benini</surname><given-names>J</given-names></name><name><surname>Pfeffer</surname><given-names>K</given-names></name></person-group><year>2000</year><article-title>Lethal granuloma disintegration in mycobacteria-infected TNFRp55&#x02212;/&#x02212; mice is dependent on T cells and IL-12.</article-title><source>J Immunol</source><volume>165</volume><fpage>483</fpage><lpage>492</lpage><pub-id pub-id-type="pmid">10861087</pub-id></citation></ref><ref id="pone.0004228-Seah1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seah</surname><given-names>GT</given-names></name><name><surname>Scott</surname><given-names>GM</given-names></name><name><surname>Rook</surname><given-names>GA</given-names></name></person-group><year>2000</year><article-title>Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis.</article-title><source>J Infect Dis</source><volume>181</volume><fpage>385</fpage><lpage>389</lpage><pub-id pub-id-type="pmid">10608794</pub-id></citation></ref><ref id="pone.0004228-vanCrevel1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Crevel</surname><given-names>R</given-names></name><name><surname>Karyadi</surname><given-names>E</given-names></name><name><surname>Preyers</surname><given-names>F</given-names></name><name><surname>Leenders</surname><given-names>M</given-names></name><name><surname>Kullberg</surname><given-names>BJ</given-names></name><etal/></person-group><year>2000</year><article-title>Increased production of interleukin 4 by CD4&#x0002b; and CD8&#x0002b; T cells from patients with tuberculosis is related to the presence of pulmonary cavities.</article-title><source>J Infect Dis</source><volume>181</volume><fpage>1194</fpage><lpage>1197</lpage><pub-id pub-id-type="pmid">10720554</pub-id></citation></ref><ref id="pone.0004228-Lynch1"><label>27</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Lynch</surname><given-names>ML</given-names></name><name><surname>Raphael</surname><given-names>SS</given-names></name><name><surname>Mellor</surname><given-names>L</given-names></name><name><surname>Spare</surname><given-names>PD</given-names></name></person-group><year>1969</year><source>Chapter 26: Medical Laboratory Technology and Clinical Pathology</source><publisher-name>M.J.H. Inwood</publisher-name><fpage>826</fpage></citation></ref><ref id="pone.0004228-Fenhalls1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fenhalls</surname><given-names>G</given-names></name><name><surname>Stevens</surname><given-names>L</given-names></name><name><surname>Bezuidenhout</surname><given-names>J</given-names></name><name><surname>Amphlett</surname><given-names>GE</given-names></name><name><surname>Duncan</surname><given-names>K</given-names></name><etal/></person-group><year>2002</year><article-title>Distribution of IFN-gamma, IL-4 and TNF-alpha protein and CD8 T cells producing IL-12p40 mRNA in human lung tuberculous granulomas.</article-title><source>Immunology</source><volume>105</volume><fpage>325</fpage><lpage>335</lpage><pub-id pub-id-type="pmid">11918694</pub-id></citation></ref><ref id="pone.0004228-Fenhalls2"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fenhalls</surname><given-names>G</given-names></name><name><surname>Wong</surname><given-names>A</given-names></name><name><surname>Bezuidenhout</surname><given-names>J</given-names></name><name><surname>Van Helden</surname><given-names>P</given-names></name><name><surname>Bardin</surname><given-names>P</given-names></name><etal/></person-group><year>2000</year><article-title>In situ production of gamma interferon, interleukin-4, and tumor necrosis factor alpha mRNA in human lung tuberculous granulomas.</article-title><source>Infect Immun</source><volume>68</volume><fpage>2827</fpage><lpage>2836</lpage><pub-id pub-id-type="pmid">10768979</pub-id></citation></ref><ref id="pone.0004228-Hoefakker1"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoefakker</surname><given-names>S</given-names></name><name><surname>Boersma</surname><given-names>WJ</given-names></name><name><surname>Claassen</surname><given-names>E</given-names></name></person-group><year>1995</year><article-title>Detection of human cytokines in situ using antibody and probe based methods.</article-title><source>J Immunol Methods</source><volume>185</volume><fpage>149</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">7561126</pub-id></citation></ref><ref id="pone.0004228-Myatt1"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Myatt</surname><given-names>N</given-names></name><name><surname>Coghill</surname><given-names>G</given-names></name><name><surname>Morrison</surname><given-names>K</given-names></name><name><surname>Jones</surname><given-names>D</given-names></name><name><surname>Cree</surname><given-names>IA</given-names></name></person-group><year>1994</year><article-title>Detection of tumour necrosis factor alpha in sarcoidosis and tuberculosis granulomas using in situ hybridisation.</article-title><source>J Clin Pathol</source><volume>47</volume><fpage>423</fpage><lpage>426</lpage><pub-id pub-id-type="pmid">8027394</pub-id></citation></ref><ref id="pone.0004228-Jalapathy1"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jalapathy</surname><given-names>KV</given-names></name><name><surname>Prabha</surname><given-names>C</given-names></name><name><surname>Das</surname><given-names>SD</given-names></name></person-group><year>2004</year><article-title>Correlates of protective immune response in tuberculous pleuritis.</article-title><source>FEMS Immunol Med Microbiol</source><volume>40</volume><fpage>139</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">14987732</pub-id></citation></ref><ref id="pone.0004228-Lucas1"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lucas</surname><given-names>SB</given-names></name><name><surname>Hounnou</surname><given-names>A</given-names></name><name><surname>Peacock</surname><given-names>C</given-names></name><name><surname>Beaumel</surname><given-names>A</given-names></name><name><surname>Djomand</surname><given-names>G</given-names></name><etal/></person-group><year>1993</year><article-title>The mortality and pathology of HIV infection in a west African city.</article-title><source>AIDS</source><volume>7</volume><fpage>1569</fpage><lpage>1579</lpage><pub-id pub-id-type="pmid">7904450</pub-id></citation></ref><ref id="pone.0004228-deNoronha1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Noronha</surname><given-names>ALL</given-names></name><name><surname>B&#x000e1;fica</surname><given-names>A</given-names></name><name><surname>Nogueira</surname><given-names>L</given-names></name><name><surname>Barral</surname><given-names>A</given-names></name><name><surname>Barral-Netto</surname><given-names>M</given-names></name></person-group><year>2008</year><article-title>Lung granulomas from <italic>Mycobacterium tuberculosis</italic>/HIV-1 co-infected patients display decreased <italic>in situ</italic> TNF production.</article-title><source>Path Res Pract</source><volume>204</volume><fpage>155</fpage><lpage>161</lpage><pub-id pub-id-type="pmid">18096327</pub-id></citation></ref><ref id="pone.0004228-Barnes2"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barnes</surname><given-names>PF</given-names></name><name><surname>Mistry</surname><given-names>SD</given-names></name><name><surname>Cooper</surname><given-names>CL</given-names></name><name><surname>Pirmez</surname><given-names>C</given-names></name><name><surname>Rea</surname><given-names>TH</given-names></name><etal/></person-group><year>1989</year><article-title>Compartmentalization of a CD4&#x0002b; T lymphocyte subpopulation in tuberculous pleuritis.</article-title><source>J Immunol</source><volume>142</volume><fpage>1114</fpage><lpage>1119</lpage><pub-id pub-id-type="pmid">2464638</pub-id></citation></ref><ref id="pone.0004228-Roach1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roach</surname><given-names>DR</given-names></name><name><surname>Bean</surname><given-names>AG</given-names></name><name><surname>Demangel</surname><given-names>C</given-names></name><name><surname>France</surname><given-names>MP</given-names></name><name><surname>Briscoe</surname><given-names>H</given-names></name><etal/></person-group><year>2002</year><article-title>TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection.</article-title><source>J Immunol</source><volume>168</volume><fpage>4620</fpage><lpage>4627</lpage><pub-id pub-id-type="pmid">11971010</pub-id></citation></ref><ref id="pone.0004228-Fayyazi1"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fayyazi</surname><given-names>A</given-names></name><name><surname>Eichmeyer</surname><given-names>B</given-names></name><name><surname>Soruri</surname><given-names>A</given-names></name><name><surname>Schweyer</surname><given-names>S</given-names></name><name><surname>Herms</surname><given-names>J</given-names></name><etal/></person-group><year>2000</year><article-title>Apoptosis of macrophages and T cells in tuberculosis associated caseous necrosis.</article-title><source>J Pathol</source><volume>191</volume><fpage>417</fpage><lpage>425</lpage><pub-id pub-id-type="pmid">10918217</pub-id></citation></ref><ref id="pone.0004228-Keane1"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keane</surname><given-names>J</given-names></name><name><surname>Balcewicz-Sablinska</surname><given-names>MK</given-names></name><name><surname>Remold</surname><given-names>HG</given-names></name><name><surname>Chupp</surname><given-names>GL</given-names></name><name><surname>Meek</surname><given-names>BB</given-names></name><etal/></person-group><year>1997</year><article-title>Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis.</article-title><source>Infect Immun</source><volume>65</volume><fpage>298</fpage><lpage>304</lpage><pub-id pub-id-type="pmid">8975927</pub-id></citation></ref><ref id="pone.0004228-Carswell1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carswell</surname><given-names>EA</given-names></name><name><surname>Old</surname><given-names>LJ</given-names></name><name><surname>Kassel</surname><given-names>RL</given-names></name><name><surname>Green</surname><given-names>S</given-names></name><name><surname>Fiore</surname><given-names>N</given-names></name><etal/></person-group><year>1975</year><article-title>An endotoxin-induced serum factor that causes necrosis of tumors.</article-title><source>Proc Natl Acad Sci USA</source><volume>72</volume><fpage>3666</fpage><lpage>3670</lpage><pub-id pub-id-type="pmid">1103152</pub-id></citation></ref><ref id="pone.0004228-Rath1"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rath</surname><given-names>PC</given-names></name><name><surname>Aggarwal</surname><given-names>BB</given-names></name><etal/></person-group><year>1999</year><article-title>TNF-induced signaling in apoptosis.</article-title><source>J Clin Immunol</source><volume>19</volume><fpage>350</fpage><lpage>364</lpage><pub-id pub-id-type="pmid">10634209</pub-id></citation></ref><ref id="pone.0004228-Viorritto1"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Viorritto</surname><given-names>IC</given-names></name><name><surname>Nikolov</surname><given-names>NP</given-names></name><name><surname>Siegel</surname><given-names>RM</given-names></name><etal/></person-group><year>2007</year><article-title>Autoimmunity versus tolerance: can dying cells tip the balance?</article-title><source>Clin Immunol</source><volume>122</volume><fpage>125</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">17029966</pub-id></citation></ref><ref id="pone.0004228-RydellTormanen1"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rydell-Tormanen</surname><given-names>K</given-names></name><name><surname>Uller</surname><given-names>L</given-names></name><name><surname>Erjefalt</surname><given-names>JS</given-names></name></person-group><year>2006</year><article-title>Direct evidence of secondary necrosis of neutrophils during intense lung inflammation.</article-title><source>Eur Respir J</source><volume>28</volume><fpage>268</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">16510453</pub-id></citation></ref><ref id="pone.0004228-Lee1"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Remold</surname><given-names>HG</given-names></name><name><surname>Leong</surname><given-names>MH</given-names></name><name><surname>Kornfeld</surname><given-names>H</given-names></name></person-group><year>2006</year><article-title>Macrophage apoptosis in response to high intracellular burden of Mycobacterium tuberculosis is mediated by a novel caspase-independent pathway.</article-title><source>J Immunol</source><volume>176</volume><fpage>4267</fpage><lpage>4274</lpage><pub-id pub-id-type="pmid">16547264</pub-id></citation></ref><ref id="pone.0004228-Fairbairn1"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fairbairn</surname><given-names>IP</given-names></name></person-group><year>2004</year><article-title>Macrophage apoptosis in host immunity to mycobacterial infections.</article-title><source>Biochem Soc Trans</source><volume>32</volume><fpage>496</fpage><lpage>498</lpage><pub-id pub-id-type="pmid">15157170</pub-id></citation></ref><ref id="pone.0004228-Hirsch1"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirsch</surname><given-names>CS</given-names></name><name><surname>Toossi</surname><given-names>Z</given-names></name><name><surname>Vanham</surname><given-names>G</given-names></name><name><surname>Johnson</surname><given-names>JL</given-names></name><name><surname>Peters</surname><given-names>P</given-names></name><etal/></person-group><year>1999</year><article-title>Apoptosis and T cell hyporesponsiveness in pulmonary tuberculosis.</article-title><source>J Infect Dis</source><volume>179</volume><fpage>945</fpage><lpage>953</lpage><pub-id pub-id-type="pmid">10068591</pub-id></citation></ref><ref id="pone.0004228-Das1"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>SD</given-names></name><name><surname>Subramanian</surname><given-names>D</given-names></name><name><surname>Prabha</surname><given-names>C</given-names></name></person-group><year>2004</year><article-title>Cell proliferation and apoptosis: dual-signal hypothesis tested in tuberculous pleuritis using mycobacterial antigens.</article-title><source>FEMS Immunol Med Microbiol</source><volume>41</volume><fpage>85</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">15094171</pub-id></citation></ref><ref id="pone.0004228-Uhal1"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uhal</surname><given-names>BD</given-names></name></person-group><year>2002</year><article-title>Apoptosis in lung fibrosis and repair.</article-title><source>Chest</source><volume>122</volume><fpage>293S</fpage><lpage>298S</lpage><pub-id pub-id-type="pmid">12475803</pub-id></citation></ref><ref id="pone.0004228-Condos1"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Condos</surname><given-names>R</given-names></name><name><surname>Rom</surname><given-names>WN</given-names></name><name><surname>Liu</surname><given-names>YM</given-names></name><name><surname>Schluger</surname><given-names>NW</given-names></name></person-group><year>1998</year><article-title>Local immune responses correlate with presentation and outcome in tuberculosis.</article-title><source>Am J Respir Crit Care Med</source><volume>157</volume><fpage>729</fpage><lpage>735</lpage><pub-id pub-id-type="pmid">9517583</pub-id></citation></ref><ref id="pone.0004228-Tan1"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>JS</given-names></name><name><surname>Canaday</surname><given-names>DH</given-names></name><name><surname>Boom</surname><given-names>WH</given-names></name><name><surname>Balaji</surname><given-names>KN</given-names></name><name><surname>Schwander</surname><given-names>SK</given-names></name><etal/></person-group><year>1997</year><article-title>Human alveolar T lymphocyte responses to Mycobacterium tuberculosis antigens: role for CD4&#x0002b; and CD8&#x0002b; cytotoxic T cells and relative resistance of alveolar macrophages to lysis.</article-title><source>J Immunol</source><volume>159</volume><fpage>290</fpage><lpage>297</lpage><pub-id pub-id-type="pmid">9200465</pub-id></citation></ref><ref id="pone.0004228-Gately1"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gately</surname><given-names>MK</given-names></name><name><surname>Renzetti</surname><given-names>LM</given-names></name><name><surname>Magram</surname><given-names>J</given-names></name><name><surname>Stern</surname><given-names>AS</given-names></name><name><surname>Adorini</surname><given-names>L</given-names></name><etal/></person-group><year>1998</year><article-title>The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses.</article-title><source>Annu Rev Immunol</source><volume>16</volume><fpage>495</fpage><lpage>521</lpage><pub-id pub-id-type="pmid">9597139</pub-id></citation></ref><ref id="pone.0004228-Jouanguy1"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jouanguy</surname><given-names>E</given-names></name><name><surname>Altare</surname><given-names>F</given-names></name><name><surname>Lamhamedi</surname><given-names>S</given-names></name><name><surname>Revy</surname><given-names>P</given-names></name><name><surname>Emile</surname><given-names>JF</given-names></name><etal/></person-group><year>1996</year><article-title>Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection.</article-title><source>N Engl J Med</source><volume>335</volume><fpage>1956</fpage><lpage>1961</lpage><pub-id pub-id-type="pmid">8960475</pub-id></citation></ref><ref id="pone.0004228-Zhang1"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Gong</surname><given-names>J</given-names></name><name><surname>Presky</surname><given-names>DH</given-names></name><name><surname>Xue</surname><given-names>W</given-names></name><name><surname>Barnes</surname><given-names>PF</given-names></name></person-group><year>1999</year><article-title>Expression of the IL-12 receptor beta 1 and beta 2 subunits in human tuberculosis.</article-title><source>J Immunol</source><volume>162</volume><fpage>2441</fpage><lpage>2447</lpage><pub-id pub-id-type="pmid">9973527</pub-id></citation></ref><ref id="pone.0004228-Wigginton1"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wigginton</surname><given-names>JE</given-names></name><name><surname>Kirschner</surname><given-names>D</given-names></name></person-group><year>2001</year><article-title>A model to predict cell-mediated immune regulatory mechanisms during human infection with Mycobacterium tuberculosis.</article-title><source>J Immunol</source><volume>166</volume><fpage>1951</fpage><lpage>1967</lpage><pub-id pub-id-type="pmid">11160244</pub-id></citation></ref><ref id="pone.0004228-Dorman1"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dorman</surname><given-names>SE</given-names></name><name><surname>Holland</surname><given-names>SM</given-names></name></person-group><year>1998</year><article-title>Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection.</article-title><source>J Clin Invest</source><volume>101</volume><fpage>2364</fpage><lpage>2369</lpage><pub-id pub-id-type="pmid">9616207</pub-id></citation></ref><ref id="pone.0004228-Subramanyam1"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Subramanyam</surname><given-names>S</given-names></name><name><surname>Hanna</surname><given-names>LE</given-names></name><name><surname>Venkatesan</surname><given-names>P</given-names></name><name><surname>Sankaran</surname><given-names>K</given-names></name><name><surname>Narayanan</surname><given-names>PR</given-names></name><etal/></person-group><year>2004</year><article-title>HIV alters plasma and M. tuberculosis-induced cytokine production in patients with tuberculosis.</article-title><source>J Interferon Cytokine Res</source><volume>24</volume><fpage>101</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">14980074</pub-id></citation></ref><ref id="pone.0004228-HernandezPando1"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hernandez-Pando</surname><given-names>R</given-names></name><name><surname>Rook</surname><given-names>GA</given-names></name></person-group><year>1994</year><article-title>The role of TNF-alpha in T-cell-mediated inflammation depends on the Th1/Th2 cytokine balance.</article-title><source>Immunology</source><volume>82</volume><fpage>591</fpage><lpage>595</lpage><pub-id pub-id-type="pmid">7835922</pub-id></citation></ref><ref id="pone.0004228-Muller1"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>KM</given-names></name><name><surname>Jaunin</surname><given-names>F</given-names></name><name><surname>Masouye</surname><given-names>I</given-names></name><name><surname>Saurat</surname><given-names>JH</given-names></name><name><surname>Hauser</surname><given-names>C</given-names></name></person-group><year>1993</year><article-title>Th2 cells mediate IL-4-dependent local tissue inflammation.</article-title><source>J Immunol</source><volume>150</volume><fpage>5576</fpage><lpage>5584</lpage><pub-id pub-id-type="pmid">8515077</pub-id></citation></ref><ref id="pone.0004228-Dheda1"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dheda</surname><given-names>K</given-names></name><name><surname>Booth</surname><given-names>H</given-names></name><name><surname>Huggett</surname><given-names>JF</given-names></name><name><surname>Johnson</surname><given-names>MA</given-names></name><name><surname>Zumla</surname><given-names>A</given-names></name><etal/></person-group><year>2005</year><article-title>Lung remodelling in pulmonary tuberculosis.</article-title><source>J Infect Dis</source><volume>192</volume><fpage>1201</fpage><lpage>1210</lpage><pub-id pub-id-type="pmid">16136463</pub-id></citation></ref><ref id="pone.0004228-Dheda2"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dheda</surname><given-names>K</given-names></name><name><surname>Chang</surname><given-names>JS</given-names></name><name><surname>Breen</surname><given-names>RAM</given-names></name><name><surname>Kim</surname><given-names>LU</given-names></name><name><surname>Haddock</surname><given-names>JA</given-names></name><etal/></person-group><year>2005</year><article-title><italic>In vivo</italic> and <italic>in vitro</italic> studies of a novel cytokine, interleukin4delta2, in pulmonary tuberculosis.</article-title><source>Am J Respir Crit Care Med</source><volume>172</volume><fpage>501</fpage><lpage>508</lpage><pub-id pub-id-type="pmid">15901609</pub-id></citation></ref><ref id="pone.0004228-Dheda3"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dheda</surname><given-names>K</given-names></name><name><surname>Chang</surname><given-names>JS</given-names></name><name><surname>Breen</surname><given-names>RAM</given-names></name><name><surname>Haddock</surname><given-names>JA</given-names></name><name><surname>Lipman</surname><given-names>MC</given-names></name><etal/></person-group><year>2005</year><article-title>Expression of a novel cytokine, IL-4delta2, in HIV and HIV-tuberculosis coinfection.</article-title><source>AIDS</source><volume>19</volume><fpage>1601</fpage><lpage>1606</lpage><pub-id pub-id-type="pmid">16184029</pub-id></citation></ref><ref id="pone.0004228-Hart1"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hart</surname><given-names>DN</given-names></name></person-group><year>1997</year><article-title>Dendritic cells: unique leukocyte populations which control the primary immune response.</article-title><source>Blood</source><volume>90</volume><fpage>3245</fpage><lpage>3287</lpage><pub-id pub-id-type="pmid">9345009</pub-id></citation></ref><ref id="pone.0004228-Trinchieri1"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trinchieri</surname><given-names>G</given-names></name></person-group><year>2003</year><article-title>Interleukin-12 and the regulation of innate resistance and adaptive immunity.</article-title><source>Nat Rev Immunol</source><volume>3</volume><fpage>133</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">12563297</pub-id></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>GlaxoSmithKline Action TB, South African MRC, South African National Research Foundation, University of Stellenbosch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article> 